J. Sels

发表

Comparison of Different Insulin Regimens in Elderly Patients With NIDDM

B. Wolffenbuttel, P. Menheere, J. Sels, 1996, Diabetes Care.

Restoration of Muscle Mitochondrial Function and Metabolic Flexibility in Type 2 Diabetes by Exercise Training Is Paralleled by Increased Myocellular Fat Storage and Improved Insulin Sensitivity

Ruth C. R. Meex, P. Schrauwen, J. Sels, 2009, Diabetes.

Rosiglitazone

M. Huijberts, B. Wolffenbuttel, J. Sels, 2001, Expert opinion on pharmacotherapy.

Lipoprotein(a) levels in relation to diabetic complications in patients with non‐insuIin‐dependent diabetes

B. Wolffenbuttel, P. Menheere, J. Sels, 1993, European journal of clinical investigation.

Clinical characteristics and management of diabetic patients residing in a nursing home.

B. Wolffenbuttel, J. Sels, A. C. Nieuwenhuijzen Kruseman, 1991, Diabetes research and clinical practice.

Prognostic factors for successful insulin therapy in subjects with type 2 diabetes.

B. Wolffenbuttel, P. Menheere, J. Sels, 1999, The Netherlands journal of medicine.

Miglitol, a new alpha-glucosidase inhibitor.

M. Huijberts, B. Wolffenbuttel, J. Sels, 1999, Expert opinion on pharmacotherapy.

Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM

B. Wolffenbuttel, P. Menheere, J. Sels, 2004, European Journal of Clinical Pharmacology.

Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus.

A. Russell, P. Schrauwen, M. Hesselink, 2007, International journal of obesity.

Untreated classical galactosemia patient with mild phenotype.

L. V. van Loon, J. Sels, M. Rubio-Gozalbo, 2006, Molecular genetics and metabolism.

Reduced skeletal muscle uncoupling protein-3 content in prediabetic subjects and type 2 diabetic patients: restoration by rosiglitazone treatment.

A. Russell, P. Schrauwen, J. Sels, 2006, The Journal of clinical endocrinology and metabolism.

Effects of acarbose (Glucobay) in persons with type 1 diabetes: a multicentre study.

B. Wolffenbuttel, J. Sels, H. Verdonk, 1998, Diabetes research and clinical practice.

α-Glucosidase Inhibition by Miglitol in NIDDM Patients

P. Menheere, J. Sels, A. Kruseman, 1992, Diabetes Care.

Improved Blood Glucose Control by Insulin Therapy in Type 2 Diabetic Patients Has No Effect on Lipoprotein(a) Levels

B. Wolffenbuttel, P. Menheere, J. Sels, 1993, Diabetic medicine : a journal of the British Diabetic Association.

Clinical experience with Sandostatin LAR in patients with acromegaly.

E. Beuls, B. Wolffenbuttel, P. Menheere, 2001, The Netherlands journal of medicine.

Gastrointestinal symptoms in diabetes mellitus, and their relation to anxiety and depression.

I. Arts, N. Schaper, J. Sels, 2012, Diabetes research and clinical practice.

Lipoprotein(A) Levels and Diabetes Control

B. Wolffenbuttel, P. Menheere, J. Sels, 1992, Diabetes Care.

Effect of atorvastatin on LDL oxidation and antioxidants in normocholesterolemic type 2 diabetic patients.

B. Wolffenbuttel, J. Sels, G. Rondas-Colbers, 2001, Clinica chimica acta; international journal of clinical chemistry.

The influence of guar-gum bread on the regulation of diabetes mellitus type II in elderly patients

J. Sels, J. Flendrig, T. Postmes, 1987, British Journal of Nutrition.

Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients

Joris Hoeks, Patrick Schrauwen, P. Schrauwen, 2008, Diabetes.

Glucagon-stimulated insulin secretion in patients with type 2 diabetes mellitus: support for the concept of glucose toxicity.

B. Wolffenbuttel, P. Menheere, J. Sels, 1992, The Netherlands journal of medicine.

Pitfall of the accessory spleen.

B. Wolffenbuttel, J. Sels, R. Lamers, 2000, The Netherlands journal of medicine.

Non-alcoholic steatohepatitis: review of a growing medical problem.

R. Stockbrugger, J. Sels, A. Driessen, 2004, European journal of internal medicine.

Measures of bioavailable serum testosterone and estradiol and their relationships with muscle mass, muscle strength and bone mineral density in postmenopausal women: a cross-sectional study.

G. Dinant, P. Geusens, B. Winkens, 2009, European journal of endocrinology.

Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1α and PPARβ/δ gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus

A. Russell, P. Schrauwen, M. Hesselink, 2007, International Journal of Obesity.

The insulin-sensitizing effect of rosiglitazone in type 2 diabetes mellitus patients does not require improved in vivo muscle mitochondrial function.

P. Schrauwen, M. Hesselink, J. Sels, 2008, The Journal of clinical endocrinology and metabolism.

Changes in thyroid status in pregnant women treated with ritodrine.

G. Essed, P. Menheere, J. Sels, 1987, European journal of obstetrics, gynecology, and reproductive biology.

Portal hypertension and intrahepatic cholestasis in hepatic amyloidosis.

J. Arends, J. Sels, J. Flendrig, 1991, The Netherlands journal of medicine.

A survey of natural protein intake in Dutch phenylketonuria patients: insight into estimation or measurement of dietary intake.

G. Boers, H. D. de Valk, J. Sels, 2008, Journal of the American Dietetic Association.

Miglitol (Bay m 1099) has no extraintestinal effects on glucose control in healthy volunteers.

B. Wolffenbuttel, P. Menheere, J. Sels, 1996, British journal of clinical pharmacology.

alpha-Glucosidase inhibition by miglitol in NIDDM patients.

P. Menheere, J. Sels, P. Kingma, 1992, Diabetes Care.

Effect of miglitol (BAY m-1099) on fasting blood glucose in type 2 diabetes mellitus.

B. Wolffenbuttel, P. Menheere, J. Sels, 1994, The Netherlands journal of medicine.

Effects of acarbose (Glucobay) in persons with type 1 diabetes: a multicentre study.

B. Wolffenbuttel, J. Sels, H. Verdonk, 1998, Diabetes research and clinical practice.